Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 1.


Abraham, J., Coleman, R., Elias, A. et al. (9 more authors) (2018) Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG). Breast Cancer Research and Treatment, 171 (1). pp. 11-20. ISSN 0167-6806

This list was generated on Sun Jan 19 23:25:33 2020 GMT.